Literature DB >> 19732062

Aminoethyl nitrate--the novel super nitrate?

Johann Bauersachs1.   

Abstract

Long-term use of most organic nitrates is limited by development of tolerance, induction of oxidative stress and endothelial dysfunction. In this issue of the BJP, Schuhmacher et al. characterized a novel class of organic nitrates with amino moieties (aminoalkyl nitrates). Aminoethyl nitrate was identified as a novel organic mononitrate with high potency but devoid of induction of mitochondrial oxidative stress. Cross-tolerance to nitroglycerin or the endothelium-dependent agonist acetylcholine after in vivo treatment was not observed. Like all nitrates, aminoethyl nitrate induced vasorelaxation by activation of soluble guanylate cyclase. Thus, in contrast to the prevailing view, high potency in an organic nitrate is not necessarily accompanied by induction of oxidative stress or endothelial dysfunction. This work from Daiber's group is an important step forward in the understanding of nitrate bioactivation, tolerance phenomena and towards the development of better organic nitrates for clinical use.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19732062      PMCID: PMC2757690          DOI: 10.1111/j.1476-5381.2009.00414.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

1.  Differential effects of organic nitrates on endothelial progenitor cells are determined by oxidative stress.

Authors:  Thomas Thum; Daniela Fraccarollo; Sabrina Thum; Maximilian Schultheiss; Andreas Daiber; Philip Wenzel; Thomas Munzel; Georg Ertl; Johann Bauersachs
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-01-25       Impact factor: 8.311

2.  Do we still need organic nitrates?

Authors:  Thomas Münzel; Philip Wenzel; Andreas Daiber
Journal:  J Am Coll Cardiol       Date:  2007-03-23       Impact factor: 24.094

3.  Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction.

Authors:  Daniela Fraccarollo; Julian D Widder; Paolo Galuppo; Thomas Thum; Dimitrios Tsikas; Michael Hoffmann; Hartmut Ruetten; Georg Ertl; Johann Bauersachs
Journal:  Circulation       Date:  2008-08-04       Impact factor: 29.690

4.  A new class of organic nitrates: investigations on bioactivation, tolerance and cross-tolerance phenomena.

Authors:  S Schuhmacher; E Schulz; M Oelze; A König; C Roegler; K Lange; L Sydow; T Kawamoto; P Wenzel; T Münzel; J Lehmann; A Daiber
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

5.  Soluble guanylyl cyclase activation with HMR1766 attenuates platelet activation in diabetic rats.

Authors:  Andreas Schäfer; Ulrike Flierl; Anna Kobsar; Martin Eigenthaler; Georg Ertl; Johann Bauersachs
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-10-05       Impact factor: 8.311

6.  Does nitric oxide mediate the vasodilator activity of nitroglycerin?

Authors:  Andrei L Kleschyov; Matthias Oelze; Andreas Daiber; Yale Huang; Hanke Mollnau; Eberhard Schulz; Karsten Sydow; Birgit Fichtlscherer; Alexander Mülsch; Thomas Münzel
Journal:  Circ Res       Date:  2003-10-09       Impact factor: 17.367

7.  Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug.

Authors:  T Münzel; S Kurz; S Rajagopalan; M Thoenes; W R Berrington; J A Thompson; B A Freeman; D G Harrison
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

8.  Once daily therapy with isosorbide-5-mononitrate causes endothelial dysfunction in humans: evidence of a free-radical-mediated mechanism.

Authors:  George R Thomas; Jonathan M DiFabio; Tommaso Gori; John D Parker
Journal:  J Am Coll Cardiol       Date:  2007-03-12       Impact factor: 24.094

9.  Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance.

Authors:  Karsten Sydow; Andreas Daiber; Matthias Oelze; Zhiqiang Chen; Michael August; Maria Wendt; Volker Ullrich; Alexander Mülsch; Eberhard Schulz; John F Keaney; Jonathan S Stamler; Thomas Münzel
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

  9 in total
  3 in total

1.  2-Aminoethylnitrate: Earlier investigation as a drug was missed by recent authors due to changes in nomenclature.

Authors:  John Christie McGrath
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

2.  Response to a letter to the editor by Satvika Uppu.

Authors:  Andreas Daiber
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

3.  2-Aminoethylnitrate: pharmacological uses rediscovered and claimed as original.

Authors:  Satvika Uppu
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.